@misc{indiciaed6f17454f490,
  title = {Automated and closed clinical-grade manufacturing protocol produces potent NK cells against neuroblastoma cells and AML blasts},
  author = {Jahan, F. and Penna, L. and Luostarinen, A. and Veltman, L. and Hongisto, H. and Lähteenmäki, K. and Müller, S. and Ylä-Herttuala, S. and Korhonen, M. and Vettenranta, K. and Laitinen, A. and Salmenniemi, U. and Kerkelä, E.},
  year = {2024},
  doi = {10.1101/2024.05.12.593780},
  url = {https://www.biorxiv.org/content/10.1101/2024.05.12.593780v1},
  note = {Source identifier: 10.1101/2024.05.12.593780}
}